Skip to main content
Logo of UNAIDS

Results and 
Transparency Portal

toggle

Main navigation

  • Home
  • Joint Programme
    • UNAIDS in Action
    • 2022-2026 UBRAF
    • UN Reform & the 2030 Agenda
  • Results
    • UNAIDS Results
    • Result Areas
    • Regions
    • Countries
    • Cosponsors
    • Performance Indicators
    • Secretariat
  • Resources and Investments
    • Resources and Investments
    • IATI
  • Donors
    • UNAIDS Resources Mobilization
    • UNAIDS Contributors
    • Evaluation, Audit and Risk Management
  • Documents Library
Search
Filter By:
Strategy/Framework/UN Reform/Reports
Result Area
Regions
Agency
Countries
Content Type
Year
Banner Image of Paediatric AIDS, vertical transmission
infoCredit: UNAIDSinfoCredit: UNAIDS
Result Area 3

Paediatric AIDS, Vertical Transmission

HIV Prevention
HIV Treatment
Paediatric AIDS, Vertical Transmission
Community-led responses
Human Rights
Gender Equality
Young People
Fully funded HIV response
Integration and Social Protection
Humanitarian Settings and Pandemics

Paediatric AIDS, Vertical Transmission

Overview
Joint Programme Results
Investments
Resources
Other Resources
Overview

Far fewer children aged 0–14 years are acquiring HIV, a trend that is due largely to successes in eastern and southern Africa, where the annual number of new HIV infections in children fell by 73% between 2010 and 2023. The overall decline in vertical HIV infections, however, has slowed markedly in recent years, particularly in western and central Africa. An estimated 120 000 [83 000–170 000] children acquired HIV in 2023, bringing the total number of children living with HIV globally to 1.4 million [1.1 million–1.7 million], 86% of whom are in sub-Saharan Africa

Namibia became the first country in Africa––and the first in the world with a high burden of HIV––to reach a significant milestone on the path towards eliminating vertical transmission of both HIV and viral hepatitis B, while Jamaica was certified for eliminating vertical transmission of HIV and syphilis. By the end of 2024, 21 countries and territories had been certified for eliminating vertical transmission of HIV and/or syphilis.
 

Number of new HIV child infections vs number of infections averted due to PMTCT
Source: AIDSinfo
Coverage of people receiving ART - by age
Source: AIDSinfo
Joint Programme Results

In 2025, the Joint Programme's guidance and technical assistance helped reduce gaps in access to paediatric HIV treatment and vertical transmission services across all regions, with a focus on high-burden countries. Updated normative guidance was rapidly developed on the WHO Triple Elimination Framework, to help countries and stakeholders in planning targeted and country-specific programmes to achieve the triple elimination of mother-to-child transmission of HIV, syphilis and hepatitis B virus. WHO and UNICEF published a country guidance for planning triple elimination of mother-to-child transmission of HIV, syphilis and hepatitis B. WHO also published an implementation guidance that supports children and adolescents living with HIV in the process of disclosure. By end of 2025, 121 countries reported having national plans aimed at eliminating vertical HIV transmission, and 106 adopted “Treat All” policies for pregnant and breastfeeding women living with HIV. Among the 37 UNICEF-supported priority countries, 33 expanded paediatric interventions and all adopted innovative diagnostics integrated into primary healthcare in 2025.

Under UNICEF’s leadership, the Joint Programme provided targeted technical guidance on national HIV and maternal, newborn and child health plans, triple elimination policies, paediatric HIV case finding and multisectoral prevention strategies through strengthened primary healthcare. Efforts established sustainability pathways for diagnostics and ART, including through the strategic use of Global Fund allocations and from leveraging domestic financing. Service delivery achievements included scaling up of early infant diagnosis, decentralizing paediatric ART to community levels, and strengthening clinical mentoring, while disaggregated data collection allowed countries to track performance and target interventions for children most at risk of HIV.

WHO, UNICEF and the Secretariat continued to support the Global Alliance to End AIDS in Children to close paediatric HIV treatment and vertical transmission gaps across 12 high-burden African countries, such as by integrating key interventions into national responses and funding proposals for Global Fund and PEPFAR. The Joint Programme provided targeted country-level support in the Central African Republic, where community-to-facility linkages reached 5000 pregnant and breastfeeding women. In Venezuela, Joint Programme support enabled point-of-care and early infant diagnosis, through dual HIV and syphilis test kits provided to 40 000 pregnant women. In Tajikistan, 160 providers were capacitated, through UNFPA support, to offer voluntary HIV counselling, testing and treatment to pregnant women. 

With Joint Programme’s support, more countries progressed toward validation and certification in 2025. The Maldives became the first country to achieve triple elimination of vertical transmission of HIV, syphilis and hepatitis B, marking a groundbreaking achievement through integrated antenatal care, immunization and testing even in small island health systems. Brazil was validated for eliminating vertical transmission of HIV, Botswana reached gold tier status on the path to elimination. By the end of 2025, a total of 23 countries and territories had reached full validation or the path to elimination of vertical transmission of HIV. 

Joint Programme Specific Outputs
3.1 Countries supported to adopt updated normative guidance, recommendations and develop and share best practices for elimination of vertical transmission and optimizing HIV testing, treatment and outcome for children and adolescents living with HIV.
3.2 Regions, partners and countries guided and supported to prioritize and implement sustainable, services for eliminating vertical transmission of HIV and ending paediatric AIDS through building capacity, integration of HIV into maternal, neonatal, child and adolescent health and primary care, and through leveraging domestic and international investments.

UBRAF Indicator Data

Select year
Investments
UNAIDS Investments in
close
height="500px" scrolling="no">

Resources

  • Reports
  • Infographics
2025-Result-Area-3-report
Jun 2026
2025 Report: Result Area 3 Paediatric AIDS, Vertical Transmission
RA3_Report
Jul 2025
2024 Report: Result Area 3 Paediatric AIDS, Vertical Transmission
RA03-2022-2023
Nov 2024
2022-2023 Report: Result Area 3 Paediatric AIDS, Vertical Transmission
PCB 54_ 2022-2023 PMR Executive Summary
Jun 2024
2022–2023 PMR Executive Summary
2022-2023 PMR Results Report
Jun 2024
2022-2023 PMR Results Report
2022 RA 03_EN_0.pdf
Jul 2023
2022 Report: Result Area 3: Paediatric AIDS, vertical transmission
2022 PMR Executive Summary
Jun 2023
2022 PMR Executive Summary
2022 PMR Results Report
Jun 2023
2022 PMR Results Report
2024_Infographic_Ending-AIDS-in-Children
Jan 2026
Ending AIDS in Children (2024 Results)
Children-Infographic_Final_Edit
Nov 2024
Ending AIDS in Children (2022-2023)
FINAL_eMTCT_A4_prepress
Jul 2016
Eliminating new HIV infection among children and adolescents and accelerating treatment (2016)

Other Resources

Reducing the number of children born with HIV | UNAIDS
The Global Alliance to end AIDS in children | UNAIDS
Global Alliance to end AIDS in Children by 2030 Launch, Africa — Remarks by Winnie Byanyima | UNAIDS
Understanding measures of progress towards the 95–95–95 HIV testing, treatment and viral suppression targets | UNAIDS
Triple elimination initiative of mother-to-child transmission of HIV, syphilis and hepatitis B (who.int)
Compendium of Promising Practices on the Role of African Faith Community Interventions to End Paediatric and Adolescent HIV | UNAIDS
Homepage | GPC (unaids.org)
Logo of UNAIDS
  • X
  • Facebook
  • Instagram
  • YouTube

Copyright © 2024

UNAIDS

  • Report fraud, abuse, misconduct
  • Scam alert
  • Terms of use